What are the maximum daily dose limits for fluvoxamine in adults, elderly patients, and adolescents?

Fluvoxamine Maximum Daily Dose Limits

The maximum daily dose of fluvoxamine is 300 mg for adults and adolescents (ages 12-17), and 200 mg for children (ages 8-11), with doses above 100-150 mg administered in two divided doses rather than once daily. 1

Adult Dosing

• Start fluvoxamine at 50 mg once daily at bedtime, then increase in 50 mg increments every 4-7 days as tolerated until maximum therapeutic benefit is achieved. 1
• The absolute maximum dose is 300 mg per day for adults with obsessive-compulsive disorder (OCD) and anxiety disorders. 2, 1
• Doses exceeding 100 mg daily should be split into two divided doses, with the larger dose given at bedtime to improve tolerability. 1
• Therapeutic response typically occurs by week 6, with maximal benefit by weeks 10-12 or later, so maintain the maximum tolerated dose for at least 8-10 weeks before declaring treatment failure. 2

Adolescent Dosing (Ages 12-17)

• Begin with 25 mg once daily at bedtime in adolescents, increasing in 25 mg increments every 4-7 days as tolerated. 1
• The maximum dose for adolescents is 300 mg daily (same as adults), as pharmacokinetic studies demonstrate similar absorption patterns between adolescents and adults. 1, 3
• Doses above 50 mg should be divided into two daily doses, with the larger portion administered at bedtime. 1

Pediatric Dosing (Ages 8-11)

• Start with 25 mg once daily at bedtime in children, titrating in 25 mg increments every 4-7 days. 1
• The maximum dose for children is 200 mg per day, which is lower than the adult/adolescent maximum because steady-state plasma concentrations are 2-3 times higher in children aged 6-11 years compared to adolescents. 1, 3
• Female children may achieve therapeutic effect at lower doses than male children, requiring individualized dose adjustment. 1
• Doses exceeding 50 mg daily should be split into two divided doses, with the larger dose at bedtime. 1

Elderly and Hepatically Impaired Patients

• Elderly patients and those with hepatic impairment require lower initial doses and slower titration due to decreased fluvoxamine clearance, though specific maximum doses are not defined in guidelines. 1
• Despite reduced clearance, pharmacokinetic studies show that steady-state levels in elderly patients are not significantly different from young adults, suggesting dose adjustments should be based on tolerability rather than age alone. 4

Critical Safety Considerations

• Never combine fluvoxamine with monoamine oxidase inhibitors (MAOIs) due to absolute contraindication and high serotonin syndrome risk. 2, 1
• Monitor intensively for serotonin syndrome within 24-48 hours of dose changes, watching for confusion, agitation, tremor, clonus, hyperreflexia, muscle rigidity, and autonomic instability. 2
• Fluvoxamine is a potent CYP1A2 inhibitor and moderate inhibitor of CYP2C19, CYP2C9, CYP3A4, and CYP2D6, requiring careful review of concurrent medications and potential dose adjustments. 2
• When co-prescribing alprazolam or triazolam with fluvoxamine, reduce the benzodiazepine dose by 50% due to marked increases in benzodiazepine plasma levels. 2
• Close monitoring for suicidality is mandatory in patients ≤24 years old during the first months of treatment and after all dose adjustments. 2

Discontinuation Protocol

• Taper fluvoxamine gradually over 1-2 weeks rather than stopping abruptly to minimize discontinuation syndrome, which includes dizziness, fatigue, myalgias, headaches, nausea, insomnia, sensory disturbances, paresthesias, anxiety, and agitation. 2, 1
• Fluvoxamine is specifically associated with withdrawal symptoms, making gradual tapering particularly important. 5

Common Pitfalls to Avoid

• Do not start at doses higher than recommended (50 mg in adults, 25 mg in children/adolescents), as this increases risk of deliberate self-harm and suicide-related events. 2
• Do not exceed 300 mg daily in adults/adolescents or 200 mg daily in children, as higher doses have not demonstrated additional benefit and may increase adverse effects. 1, 3
• Do not switch medications before completing at least 8-10 weeks at maximum tolerated dose, as OCD requires higher doses and longer treatment duration than depression or other anxiety disorders. 2